The completed acquisition adds Australian yeast-breeding capabilities to Novonesis following more than a decade of collaboration and a 23% ownership stake IN BRIEFKEY TAKEAWAYSFAQs Novonesis has completed its acquisition of Australian biotechnology company MicroBioGen after obtaining all required regulatory approvals. … Read the full press release →
Posted in Business, Denmark, Investment, Pharma & Biotech
Tagged 'Novonesis', 2030 strategy, Australia, bioethanol, biosolutions, biotechnology, Claus Crone Fuglsang, Copenhagen, Denmark, Ester Baiget, industrial fermentation, industrial yeast, MicroBioGen, MicroBioGen acquisition expands Novonesis yeast-breeding and biosolutions capabilities, microbiology, Novonesis adds Australian biotechnology expertise to support new industrial biosolutions, Novonesis brings MicroBioGen into group to broaden industrial yeast expertise, Novonesis completes MicroBioGen deal after more than a decade of collaboration, R&D, research and development, yeast, yeast breeding
(IN BRIEF) Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotechnology company specialising in yeast strains for industrial applications, particularly bioethanol. The planned acquisition builds on Novonesis’ 2013 investment in MicroBioGen and its current 23 … Read the full press release →
Posted in Business, Chemicals, Denmark, Energy, Gas & Oil, Financial, Food & Beverage, Industrial, Investment, Pharma & Biotech, Science
Tagged 2013 investment, 2030 strategy, 23 percent stake, ACCC, acquisition agreement, Australia, Australian Competition and Consumer Commission, baking applications, bioethanol, biological solutions, biosolutions, biotechnology, biotechnology acquisition, Claus Crone Fuglsang, Copenhagen, customary approvals, decade-long collaboration, Denmark, disciplined investment, elite yeast genetics, energy applications, Ester Baiget, food applications, Geoffrey Bell, industrial applications, industrial fermentation, industrial yeast, Innova yeast series, MicroBioGen, microbiology, Novonesis, Novonesis Expands Yeast Capabilities Through Planned MicroBioGen Acquisition, Novonesis Targets Bioethanol and Fermentation Growth With MicroBioGen Deal, Novonesis to Acquire MicroBioGen to Strengthen Yeast Biotechnology Platform, platform technology, pure-play biology company, R&D capabilities, regulatory approvals, research and development, sustainable feed, transaction terms undisclosed, yeast biotechnology, yeast innovation as a service, yeast strains
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Digi Communications NV announces availability of Digi Spain’s H1 2026 financial results presentation
Load more...
